07/03/2026
A Breakthrough Application of the Toumai® Surgical Robot in Brazil
MicroPort® MedBot™ extends its warmest congratulations to the USP - Universidade de São Paulo on the successful completion of the first series of robotic-assisted telesurgeries within Brazil’s public healthcare system, the Sistema Único de Saúde (SUS).
All procedures were performed with the assistance of the Toumai® Surgical Robot and its cutting-edge telesurgery technology, delivering real-time, stable, and ultra-low-latency performance throughout the entire surgical process. Conducted in real-world clinical settings, these cases rigorously validated the feasibility and safety of robotic telesurgery in public healthcare environments.
This was not a technical demonstration, but a commercially implemented clinical application:
🔹 Multiple oncology-related procedures were successfully completed, including prostatectomy, neck tumor resection, partial lung resection, and radical hysterectomy for uterine cancer。The neck tumor resection was Toumai®’s first remote head and neck surgery, and the partial lung resection marked its first overseas (outside China) remote thoracic surgery;
🔹 Compared with conventional approaches, procedures demonstrated significantly improved efficiency and notably reduced blood loss;
🔹 Patients experienced faster recovery, with some discharged within 24–48 hours postoperatively;
🔹 Full on-site surgical teams and multiple layers of safety redundancy were maintained at all times to ensure clinical safety.
This milestone marks a pivotal shift—advanced surgical technologies are moving from elite centers toward broader public accessibility. As telesurgery, robotics, and minimally invasive techniques converge within public healthcare systems, the boundaries of modern medicine are being fundamentally redefined.
More importantly, this initiative directly addresses a core challenge in public healthcare: How to overcome geographical barriers and extend high-quality surgical expertise to a broader patient population——telesurgery not only enhances the precision and safety of minimally invasive surgery, but also opens new pathways for surgeon training, telementoring, and regional clinical collaboration.
This project was jointly advanced by MicroPort MedBot™ and USP in strict compliance with regulatory requirements. Device performance, network stability, and clinical workflows were validated through a phased and systematic approach, laying a solid foundation for future scaled deployment and policy implementation.
MicroPort Brasil
